Coya Therapeutics, Inc. — Form 8-K
Filed October 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Coya Therapeutics filed an 8-K on 2026-10-14 with Item 8.01 (Other Events) listed. The actual substantive content of the filing—including counterparties, dollar amounts, dates of events, and specific business developments—is not visible in the SEC filing header metadata provided. The document structure shows XBRL taxonomy extensions and 11 total documents submitted, but the narrative disclosure is absent from this text.
Why this rating
No material event disclosed in accessible text. Cannot assess business impact without actual 8-K content. Routine SEC administrative filing.
Extracted items
See more from October 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.